Description of the Side Effects of Chemotherapy Drugs in Breast Cancer Patients at RSUD Arifin Achmad Pekanbaru
Abstract
The most prevalent cancer in women, though it can strike men as well, is breast cancer. Breast cancer is brought on by unchecked cell proliferation, which, if uncontrolled, can turn into a malignant tumour. One breast cancer treatment that requires monitoring and careful attention to adverse effects is chemotherapy. Determining the adverse effects of chemotherapy on patients with breast cancer was the goal of this study. This study uses an observational, non-experimental research design that is descriptive and evaluative in nature. Data has been collected from the medical records of 16 patients with 11 chemotherapy medication regimens who satisfied the inclusion criteria and had an initial diagnosis of breast cancer in the July 2023. The seven types of chemotherapy medications that are employed are: paclitaxel, cisplatin, doxorubicin, docetaxel, carboplatin, cyclophosphamide, herzemab, and fonkopec. Docetaxel with carboplatin was the most often prescribed chemotherapeutic medication combination, accounting for 4 individuals (25%). Potential side effects that arise during treatment are mucositis, decreased appetite, nausea and vomiting, alopecia, changes in skin and nail color, myalgia, fatigue, dizziness, weakness and numbness in the legs. The side effects that consistently manifested in all patients (100%) were myalgia, alopecia, and nausea and vomiting, according to the results.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Please find the rights and licenses in Jurnal Ilmu Kesehatan Abdurrab. By submitting the article/manuscript of the article, the author(s) accept this policy.
1. License
The non-commercial use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
2. Author’s Warranties
The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
3. User Rights
Jurnal Ilmu Kesehatan Abdurrab spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, Jurnal Ilmu Kesehatan Abdurrab permits users to copy, distribute, display, and perform the work for non-commercial purposes only. Users will also need to attribute authors and Jurnal Ilmu Kesehatan Abdurrab on distributing works in the journal.
4. Rights of Authors
Authors retain all their rights to the published works, such as (but not limited to) the following rights;
- Copyright and other proprietary rights relating to the article, such as patent rights,
- The right to use the substance of the article in own future works, including lectures and books,
- The right to reproduce the article for own purposes,
- The right to self-archive the article,
- The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal (Jurnal Ilmu Kesehatan Abdurrab).
5. Co-Authorship
If the article was jointly prepared by other authors, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. Jurnal Ilmu Kesehatan Abdurrab will not be held liable for anything that may arise due to the author(s) internal dispute. Jurnal Ilmu Kesehatan Abdurrab will only communicate with the corresponding author.
6. Royalties
This agreement entitles the author to no royalties or other fees. To such extent as legally permissible, the author waives his or her right to collect royalties relative to the article in respect of any use of the article by Jurnal Ilmu Kesehatan Abdurrab.
7. Miscellaneous
Jurnal Ilmu Kesehatan Abdurrab will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed. Jurnal Ilmu Kesehatan Abdurrab's editors may modify the article to a style of punctuation, spelling, capitalization, referencing and usage that deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers as mentioned in point 3.
PDF
Abstract views: 41
downloads: 49
